The largest database of trusted experimental protocols

3 protocols using cd73 sirna

1

Inhibition of CD73 in Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
K-1 and SNU-790 cells (2 × 105) were seeded onto 60 mm dishes and incubated in antibiotic-free culture medium for 24 h at 37 °C. The cell culture medium was replaced with antibiotic-free media containing 100 µM APCP, a CD73 inhibitor (Sigma-Aldrich, St. Louis, MO, USA; No. M3763), and cultured for 24 h (K-1 cells) and 48 h (SNU-790 cells), respectively.
CD73 knockdown was conducted using a CD73 siRNA (Dharmacon, Lafayette, CO, USA; No. D-008217-01) according to the manufacturer’s instructions. The target sequence of the siRNA used was as follows: CD73-siRNA, 5′-GAACCUGGCUGCUGUAUUG-3′, and that of non-targeting siRNA was 5′-UGGUUUACAUGUCGACUAA-3′. The cells were transfected with 20 nM non-targeting siRNA or CD73 siRNA using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA; No. 11668-019).
+ Open protocol
+ Expand
2

Lipid Nanoparticle Formulation for Cancer Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
1, 2-Distearoylsn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000] (mPEG2000-DSPE), 1, 2-dioleoyl-sn-glycerol 3 phosphoethanolamine (DOPE) and 1, 2-dioleoyl-3-trimethylammonium-propane (DOTAP) were purchased from Avanti Polar Lipids (Alabaster, AL, USA), Octyl glucoside (OG), cholesterol and RPMI 1640 were purchased from Sigma-Aldrich. The lipofectamine 2000 was purchased from Invitrogen (USA). PE-conjugated anti-mouse CD73 (Cat No: 127205) and isotype-matched control monoclonal antibodies (mAbs) were purchased from Biolegend (USA). Phorbol 12-myristate 13-acetate (PMA)/ionomycin cocktail, Anti-mouse CD3-APC, anti-CD8a-PE-cy5, anti CD4-PE-cy5, CD25-FITC antibodies, anti-IFN-γ-FITC and antiIL-4-PE antibodies were purchased from BD Biosciences (San Diego, USA). CD73 siRNA and non-targeting siRNA (Cat No: D-001210-01-20) were obtained from Dharmacon (Thermo Fisher, Hilden, Germany). GE11 peptide (CGGGYHWYGYTPQNVI) with 1857 Da molecular weight and purity of 92.17% was purchased from China Peptides Co. (Shanghai, China). Liposomal Doxorubicin was purchased from Exir Nano Sina Company (Tehran, Iran). DEPC-treated water was applied in all experiments for siRNA containing samples. All other reagents were chemical grade.
+ Open protocol
+ Expand
3

Lipid-based Nanoparticle Formulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
1, 2-distearoylsn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol) -2000] (mPEG2000-DSPE), 1, 2-dioleoyl-sn-glycerol 3 phosphoethanolamine (DOPE) and 1, 2-dioleoyl-3-trimethylammoniumpropane (DOTAP) were purchased from Avanti Polar Lipids (Alabaster, AL, USA), Octyl glucoside (OG), cholesterol and RPMI 1640 were purchased from Sigma-Aldrich. The lipofectamine 2000 was purchased from Invitrogen (USA). PE-conjugated anti-mouse CD73 (Cat No: 127205) and isotype-matched control monoclonal antibodies (mAbs) were purchased from Biolegend (USA). Phorbol 12-myristate 13-acetate (PMA)/ionomycin cocktail, Anti-mouse CD3-APC, anti-CD8a-PE-cy5, anti CD4-PE-cy5, CD25-FITC antibodies, anti-IFN-γ-FITC and antiIL-4-PE antibodies were purchased from BD Biosciences (San Diego, USA). CD73 siRNA and non-targeting siRNA (Cat No: D-001210-01-20) were obtained from Dharmacon (Thermo Fisher, Hilden, Germany). GE11 peptide (CGGGYHWYGYTPQNVI) with 1857 Da molecular weight and purity of 92.17% was purchased from China Peptides Co. (Shanghai, China). Liposomal Doxorubicin was purchased from Exir Nano Sina Company (Tehran, Iran). DEPC-treated water was applied in all experiments for siRNA containing samples. All other reagents were chemical grade.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!